ICON Management
Management criteria checks 4/4
ICON's CEO is Steve Cutler, appointed in Mar 2017, has a tenure of 7.75 years. total yearly compensation is $7.24M, comprised of 16.4% salary and 83.6% bonuses, including company stock and options. directly owns 0.045% of the company’s shares, worth $7.87M. The average tenure of the management team and the board of directors is 7.8 years and 7.7 years respectively.
Key information
Steve Cutler
Chief executive officer
US$7.2m
Total compensation
| CEO salary percentage | 16.4% |
| CEO tenure | 7.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | 7.8yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 45% Discount?
Dec 28
ICON: A High Probability Of Success In The Uncertain R&D Process
Dec 13At US$219, Is ICON Public Limited Company (NASDAQ:ICLR) Worth Looking At Closely?
Dec 10ICON: Disappointing Change In Trajectory (Rating Downgrade)
Nov 29With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For
Nov 02Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors
Sep 25Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Sep 09We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
Aug 25An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued
Aug 10ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)
Jun 14Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching
May 30ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 14ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 28What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?
Apr 21ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price
Apr 05ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump
Mar 05With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Feb 07ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 23Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jan 08Icon selected by BARDA to conduct anthrax vaccine clinical trial
Oct 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$748m |
| Jun 30 2024 | n/a | n/a | US$714m |
| Mar 31 2024 | n/a | n/a | US$683m |
| Dec 31 2023 | US$7m | US$1m | US$612m |
| Sep 30 2023 | n/a | n/a | US$513m |
| Jun 30 2023 | n/a | n/a | US$510m |
| Mar 31 2023 | n/a | n/a | US$510m |
| Dec 31 2022 | US$10m | US$1m | US$505m |
| Sep 30 2022 | n/a | n/a | US$464m |
| Jun 30 2022 | n/a | n/a | US$210m |
| Mar 31 2022 | n/a | n/a | US$168m |
| Dec 31 2021 | US$10m | US$1m | US$153m |
| Sep 30 2021 | n/a | n/a | US$178m |
| Jun 30 2021 | n/a | n/a | US$364m |
| Mar 31 2021 | n/a | n/a | US$338m |
| Dec 31 2020 | US$8m | US$1m | US$328m |
| Sep 30 2020 | n/a | n/a | US$322m |
| Jun 30 2020 | n/a | n/a | US$324m |
| Mar 31 2020 | n/a | n/a | US$368m |
| Dec 31 2019 | US$8m | US$1m | US$369m |
| Sep 30 2019 | n/a | n/a | US$362m |
| Jun 30 2019 | n/a | n/a | US$353m |
| Mar 31 2019 | n/a | n/a | US$333m |
| Dec 31 2018 | US$8m | US$1m | US$323m |
| Sep 30 2018 | n/a | n/a | US$306m |
| Jun 30 2018 | n/a | n/a | US$295m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$7m | US$1m | US$281m |
Compensation vs Market: Steve's total compensation ($USD7.24M) is below average for companies of similar size in the US market ($USD12.85M).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
CEO
Steve Cutler (64 yo)
7.8yrs
Tenure
US$7,244,000
Compensation
Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7.8yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | no data | US$290.00k | 0.54% $ 95.5m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Senior Vice President of Corporate & Commercial Finance | no data | no data | no data | |
| Chief Information Officer | no data | no data | no data | |
| Chief Administrative Officer | 15.1yrs | no data | 0.0097% $ 1.7m | |
| Director of Corporate Communications | no data | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Human Resources Officer | 8.4yrs | no data | no data | |
| President of Corporate Investments & Partnerships | 2.1yrs | no data | no data | |
| Senior Vice President of Global Clinical Pharmacology | 15.7yrs | no data | no data |
7.8yrs
Average Tenure
53.5yo
Average Age
Experienced Management: ICLR's management team is seasoned and experienced (7.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 9.1yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | 14.9yrs | US$290.00k | 0.54% $ 95.5m | |
| Independent Director | 3.4yrs | US$303.00k | 0.0054% $ 941.2k | |
| Independent Non-Executive Director | 7.2yrs | US$323.00k | 0.0026% $ 450.4k | |
| Independent Non-Executive Chairman of the Board | 13.2yrs | US$656.00k | 0.023% $ 4.1m | |
| Lead Independent Director | 8.2yrs | US$359.00k | 0.0026% $ 450.4k | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.4yrs | US$315.00k | 0.0023% $ 410.1k |
7.7yrs
Average Tenure
64.5yo
Average Age
Experienced Board: ICLR's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 05:43 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ICON Public Limited Company is covered by 45 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Armelle Moulin | AlphaValue |
| Gregory Bolan | Avondale Partners |
| Eric Coldwell | Baird |